PlantForm Strikes Deal For Brazilian Pembrolizumab

Signs Agreement With Bio-Manguinhos/Fiocruz To Develop Keytruda Rival

 
• By Dave Wallace

Canada’s PlantForm has struck a deal with Brazil’s Bio-Manguinhos/Fiocruz to develop a biosimilar pembrolizumab rival to Merck’s Keytruda for the Brazilian market and potentially beyond.

Deal Handshake Brazil Canada Flags
Canada’s Plantform has struck a deal to develop a pembrolizumab biosimilar • Source: Alamy

More from Deals

More from Business